Varaico: Literature-Extracted Genetic Variants

Gene:HNF4A
Variant:p.R114W
Back to variants list

HNF4A

NM_175914.5:p.R114W

Associated Papers

Improving type 2 diabetes polygenic risk scores by incorporating rare, low-frequency, and population-specific variants.

Taylor K et al.

Medrxiv : the Preprint Server for Health Sciences, 2025

Global perspectives on monogenic forms of diabetes.

Russ-Silsby J et al.

Diabetologia, 2025

Genetic and clinical characteristics of children with mody: insights into novel HNF4A variants and genotype-phenotype correlation.

Buhur Pirimoglu M et al.

Irish Journal of Medical Science, 2025

Maturity onset diabetes of the young and beyond: the changing face of single-gene diabetes.

Laver TW et al.

European Journal of Endocrinology, 2025

Excess of rare noncoding variants in several type 2 diabetes candidate genes among Asian Indian families.

Rout M et al.

Communications Medicine, 2025

Rare variant analyses in 51,256 type 2 diabetes cases and 370,487 controls reveal the pathogenicity spectrum of monogenic diabetes genes.

Huerta-Chagoya A et al.

Nature Genetics, 2024

Genomics 2 Proteins portal: a resource and discovery tool for linking genetic screening outputs to protein sequences and structures.

Kwon S et al.

Nature Methods, 2024

39294369 (PubMed )
Supplement: 41592_2024_2409_MOESM3_ESM.pdf

Molecular mechanism of HNF-1A-mediated HNF4A gene regulation and promoter-driven HNF4A-MODY diabetes.

Kind L et al.

Jci Insight, 2024

Functional characterization of HNF4A gene variants identify promoter and cell line specific transactivation effects.

Kaci A et al.

Human Molecular Genetics, 2024

The use of precision diagnostics for monogenic diabetes: a systematic review and expert opinion.

Murphy R et al.

Communications Medicine, 2023

37794142 (PubMed )
Supplement: 43856_2023_369_MOESM2_ESM.xlsx › Supplementary_Data_1

Rare variant association analysis in 51,256 type 2 diabetes cases and 370,487 controls informs the spectrum of pathogenicity of monogenic diabetes genes.

Schroeder P et al.

Medrxiv : the Preprint Server for Health Sciences, 2023

A Systematic Review of the use of Precision Diagnostics in Monogenic Diabetes.

Murphy R et al.

Medrxiv : the Preprint Server for Health Sciences, 2023

MODY patients carrying mutation in syndromic diabetes genes. An Italian single-center experience.

Marucci A et al.

Acta Diabetologica, 2023

The effect of ascertainment on penetrance estimates for rare variants: Implications for establishing pathogenicity and for genetic counselling.

Paterson AD et al.

Plos One, 2023

Reduced penetrance of MODY-associated HNF1A/HNF4A variants but not GCK variants in clinically unselected cohorts.

Mirshahi UL et al.

American Journal of Human Genetics, 2022

Syndromic Monogenic Diabetes Genes Should Be Tested in Patients With a Clinical Suspicion of Maturity-Onset Diabetes of the Young.

Colclough K et al.

Diabetes, 2022

34789499 (PubMed )
Supplement: EMS140031-supplement-Supplementary_tables_1_to_8_and_Supplementary_figure_1.pdf

Association of birthweight and penetrance of diabetes in individuals with HNF4A-MODY: a cohort study.

Locke JM et al.

Diabetologia, 2022

Exome sequencing and analysis of 454,787 UK Biobank participants.

Backman JD et al.

Nature, 2021

34662886 (PubMed )
Supplement: 41586_2021_4103_MOESM4_ESM.xlsx › ST6

Determinants of penetrance and variable expressivity in monogenic metabolic conditions across 77,184 exomes.

Goodrich JK et al.

Nature Communications, 2021

A Review of Functional Characterization of Single Amino Acid Change Mutations in HNF Transcription Factors in MODY Pathogenesis.

Çubuk H et al.

The Protein Journal, 2021

Exome Sequencing and Clinical Diagnosis.

Friedman JM et al.

Jama, 2020

How Recent Advances in Genomics Improve Precision Diagnosis and Personalized Care of Maturity-Onset Diabetes of the Young.

Vaxillaire M et al.

Current Diabetes Reports, 2019

Assessing the Pathogenicity, Penetrance, and Expressivity of Putative Disease-Causing Variants in a Population Setting.

Wright CF et al.

American Journal of Human Genetics, 2019

A UK nationwide prospective study of treatment change in MODY: genetic subtype and clinical characteristics predict optimal glycaemic control after discontinuing insulin and metformin.

Shepherd MH et al.

Diabetologia, 2018

30229274 (PubMed )
Supplement: 125_2018_4728_MOESM1_ESM.pdf

An Atypical HNF4A Mutation Which Does Not Conform to the Classic Presentation of HNF4A-MODY.

Spiro AJ et al.

Case Reports in Endocrinology, 2018

Spectrum of mutations in monogenic diabetes genes identified from high-throughput DNA sequencing of 6888 individuals.

Bansal V et al.

Bmc Medicine, 2017

Management of sulfonylurea-treated monogenic diabetes in pregnancy: implications of placental glibenclamide transfer.

Shepherd M et al.

Diabetic Medicine : a Journal of the British Diabetic Association, 2017

Precision diabetes: learning from monogenic diabetes.

Hattersley AT et al.

Diabetologia, 2017

Prolonged episodes of hypoglycaemia in HNF4A-MODY mutation carriers with IGT. Evidence of persistent hyperinsulinism into early adulthood.

Bacon S et al.

Acta Diabetologica, 2016

The Common p.R114W HNF4A Mutation Causes a Distinct Clinical Subtype of Monogenic Diabetes.

Laver TW et al.

Diabetes, 2016

Identification and Clinical Characterization of Adult Patients with Multigenerational Diabetes Mellitus.

Ludovico O et al.

Plos One, 2015

Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha and 4 alpha in maturity-onset diabetes of the young and hyperinsulinemic hypoglycemia.

Colclough K et al.

Human Mutation, 2013

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."